Cell Therapy Held Larger Share in Cell and Gene Therapy Market in 2023, full analysis by Product, Application, Source, Manufacturing, and Geography.
NEW YORK, Oct. 30, 2024 /PRNewswire/ -- According to a new market research by The Insight Partners, the Global Cell and Gene Therapy Market is experiencing significant growth owing to the surge in focus on research and development. The report runs an in-depth analysis of market trends, key players, and future opportunities. The overall cell and gene therapy market is categorized on the basis of type, services, scale, service providers, and end users.
https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg [https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg]
Read full market research report, "Cell and Gene Therapy Market Analysis and Forecast by Size, Share, Growth, Trends 2031 [https://www.theinsightpartners.com/reports/cell-and-gene-therapy-market]", published by The Insight Partners.
Overview of Report Findings
1. Market Growth: The global cell and gene therapy market is expected to
reach US$ 28,050.39 million by 2031 from US$ 4,485.00 million in 2023; it
is anticipated to record a CAGR of 25.8% during the forecast period. Cell
therapy refers to the process of transferring intact, live cells into a
patient to alleviate or sometimes cure a disease. The cells can be taken
from the patient or another donor. Cells used in cell therapy are
categorized based on their ability. Gene therapy is the application of
genetic material for the treatment or prevention of disease.
2. Emergence of Advanced Therapies: Advanced Cell and gene therapy are
rapidly transforming the biotechnology industry as it is a type of
treatment for different types of genetic disorders and chronic diseases.
Advanced cells are used as new drug delivery systems to optimize the
efficacy and action of targeted agents. Gene therapy helps improve
patient outcomes and attracts heavy investments from pharmaceutical firms
as well as from institutes conducting the research. Thus, emergence of
advanced therapies such as personalized medicine, advancements in
research and development, and favorable regulatory environments for new
therapeutic possibilities.
3. Increase in Prevalence of Cancer: Cell and gene therapy, an advanced
treatment modality, provides scope for cutting-edge alternatives to
traditional therapies. The demand for new and effective treatments
increases with the steady increase in the number of cases across the
globe. These cell treatments, when used as site-specific drug delivery
devices, will provide better-localized treatment of the tumors instead;
therefore, site-specific drug delivery devices pose less risk of side
effects and high effectiveness in therapeutics. Also, gene therapy has
indicated a revolution in cancer treatment owing to the direct
modification of genes related to cancer, thus permitting personalistic
approaches that can target specific mutations or pathways present in the
cancerous cells. The increased investment in pharmaceutical and research
labs for the development of effective therapies for cancer has resulted
in the critical need for such treatments. With this growing burden of
cancer, the research, development, and adoption of cell and gene
therapies have also grown.
4. Geographic Insights: In 2023, North America led the market with a
substantial revenue share, followed by Europe and Asia Pacific. Further,
Asia Pacific is expected to record the highest CAGR during the forecast
period.
Get Sample PDF Copy: https://www.theinsightpartners.com/sample/TIPRE00020854/ [https://www.theinsightpartners.com/sample/TIPRE00020854/?utm_source=PRNewsWire&utm_medium=10370]
Market Segmentation
-- Based on type, the cell and gene therapy market is bifurcated into cell
therapy and gene therapy. The cell therapy segment held a larger share
of the market in 2023.
-- In terms of services, the cell and gene therapy market is segmented into
process development, CGMP manufacturing, regulatory services, and
bioassay services. The process development segment led the market in
2023.
-- By scale, the cell and gene therapy market is divided into
pre-commercial/R and D manufacturing and commercial scale manufacturing.
In 2023, the pre-commercial/R and D manufacturing segment dominated the
market.
-- Based on service providers, the cell and gene therapy market is
bifurcated into CDMOs and CMOs. The CDMOs segment held a larger share of
the market in 2023.
-- By end user, the cell and gene therapy market is segmented into contract
research organizations, pharmaceutical and biopharmaceutical companies,
and academic and research institutes. In 2023, the contract research
organizations segment dominated the market.
-- The cell and gene therapy market is segmented into five major regions:
North America, Europe, APAC, the Middle East & Africa, and South &
Central America.
Get Detailed Analysis: https://www.theinsightpartners.com/reports/cell-and-gene-therapy-market/ [https://www.theinsightpartners.com/reports/cell-and-gene-therapy-market/]
Competitive Strategy and Development
-- Key Players: A few of the major companies operating in the global cell
and gene therapy market are Thermo Fisher Scientific Inc, Merck KGaA,
Charles River Laboratories, Cell and Gene Therapy Catapult, Lonza, WuXi
AppTec, Takara Bio Inc, Bristol Myers Squibb, FUJIFILM Holdings
Corporation, and F Hoffmann La Roche Ltd.
-- Trending Topics: Cell therapy, gene therapy, and cell and gene therapy
manufacturing
Global Headlines on Cell and Gene Therapy Market
-- "AstraZeneca Announces Collaboration and Investment Agreement with
Cellectis to Accelerate Cell Therapy and Genomic Medicine Ambitions"
-- "President of India Launches India's First Home-Grown Gene Therapy for
Cancer developed by IIT Bombay, Tata Memorial Centre, and ImmunoACT. "
-- "AstraZeneca to Acquire Gracell--Furthering Cell Therapy Ambition Across
Oncology and Autoimmune Diseases"
Purchase Premium Copy of Global Cell and Gene Therapy Market Growth Report at: https://www.theinsightpartners.com/buy/TIPRE00020854/ [https://www.theinsightpartners.com/buy/TIPRE00020854/?utm_source=PRNewsWire&utm_medium=10370]
Conclusion
The advancement in therapies and the increment in the prevalence of cancer are key factors responsible for the growth of the cell and gene therapy market. The market includes a wide variety of therapeutic solutions in the form of cell therapies, gene-modified cell therapies, and traditional gene therapies, which develop significant potential in sectors such as cancer care, generating more than 40% of the total revenue. In addition, growth in research and development for novel treatments is driving the market.
The report from The Insight Partners provides several stakeholders--including component providers, system technology integrators, and system manufacturers--with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities.
Check out more related reports by The Insight Partners:
Stem Cell Therapy Market Strategies, Top Players, Growth Opportunities, Analysis, and Forecast by 2031 [https://www.theinsightpartners.com/reports/stem-cell-therapy-market]
Cell Therapy Instrument Market Overview, Growth, Trends, Analysis, Research Report 2021-2031 [https://www.theinsightpartners.com/reports/cell-therapy-instruments-market]
Cell Therapy Market Forecast and Growth 2031 [https://www.theinsightpartners.com/reports/cell-therapy-market]
Cell Therapy Biomanufacturing Market Size and Forecasts 2021 - 2031, [https://www.theinsightpartners.com/reports/cell-therapy-biomanufacturing-market]
T Cell Therapy Market Analysis Report - Size & Share 2030 [https://www.theinsightpartners.com/reports/t-cell-therapy-market]
Gene Therapy For Rare Disease Market Size and Forecasts 2021 - 2031, [https://www.theinsightpartners.com/reports/gene-therapy-for-rare-disease-market]
Gene Therapy Market Size, Trends, and Growth Report by 2031 [https://www.theinsightpartners.com/reports/gene-therapy-market]
Gene Therapy For Rare Disease Market Size and Forecasts 2021 - 2031 [https://www.theinsightpartners.com/reports/gene-therapy-for-rare-disease-market]
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com [mailto:ankit.mathur@theinsightpartners.com]
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/cell-and-gene-therapy-market [https://www.theinsightpartners.com/pr/cell-and-gene-therapy-market]
Browse more The Insight Partners Pharmaceuticals Industry [https://www.theinsightpartners.com/categories/pharmaceuticals/] Research Reports
Logo: https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg [https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg]
View original content:https://www.prnewswire.co.uk/news-releases/at-25-8-cagr-cell-and-gene-therapy-market-size-to-reach-28-05-billion-by-2031--the-insight-partners-302291315.html [https://www.prnewswire.co.uk/news-releases/at-25-8-cagr-cell-and-gene-therapy-market-size-to-reach-28-05-billion-by-2031--the-insight-partners-302291315.html]
Photo: https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg The Insight Partners
